<DOC>
	<DOCNO>NCT00002034</DOCNO>
	<brief_summary>To evaluate safety tolerance long-term ganciclovir ( DHPG ) therapy newly diagnose macular threaten Cytomegalovirus ( CMV ) retinitis AIDS patient . To evaluate clinical response 52 week course intravenous DHPG therapy . To evaluate safety tolerance long-term DHPG concurrent treatment zidovudine ( AZT ) . ( Patients utilize treatment anti-retroviral drug consider study entry case case basis . ) To determine survival group patient AIDS CMV retinitis .</brief_summary>
	<brief_title>A Study Safety Tolerance Long-Term Therapy With Intravenous Cytovene ( Ganciclovir Sodium ) Cytomegalovirus Retinitis Persons With AIDS</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Topical acyclovir . Selected cytokine . Allowed first 4 week ganciclovir : Zidovudine ( AZT ) reduce dose ( 500 mg/day ) patient tolerate ganciclovir without grade 3/4 hematological toxicity . Other antiretrovirals consultation Syntex study monitor . Patients must follow : AIDS newly diagnose Cytomegalovirus ( CMV ) retinitis . An understanding nature study , agreement provision , willingness sign informed consent approve appropriate institution review board , Syntex . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Have peripheral CMV retinitis ( define lesion outside major temporal vascular arcade , great 1500 micron optic disk , great 3000 micron fovea ) . Ocular medium opacity ( corneal , lenticular , vitreal ) prevent ophthalmologic retinal assessment . Ocular condition require immediate surgical correction ( eg : retinal tear detachment ) . Demonstrated hypersensitivity acyclovir ganciclovir . Dementia , decrease mentation encephalopathic sign symptom would interfere ability patient comply protocol . Concurrent Medication : Excluded : Antimetabolites . Alkylating agent . Nucleoside analog ( exclude select antiretroviral agent ) . Imipenemcilastatin . Interferons . Selected cytokine . Acyclovir ( except topical acyclovir ) . Patients follow exclude : Have peripheral CMV retinitis ( define lesion outside major temporal vascular arcade , great 1500 micron optic disk great 3000 micron fovea ) . Concomitant condition disease describe Exclusion CoExisting Conditions . Prior Medication : Excluded within 1 month study entry : Previous treatment anticytomegalovirus therapy ( e.g. , ganciclovir , foscarnet CMV hyperimmune globulin ) .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1992</verification_date>
	<keyword>Retinitis</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>